Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.

Molecular and cellular biochemistry - 1 Sept 2014

Xu Ran, Shang Chao, Zhao Jungang, Han Yun, Liu Jun, Chen Kuanbing, Shi Wenjun

Abstract excerpt

Response gene to complement 32 (RGC32) is a novel protein originally identified as a cell cycle activator and has been demonstrated to be overexpressed in a variety of human malignancies, including lung cancer. However, the potential role of RGC32 in lung cancer initiation and progression remains...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Apoptosis Regulatory Proteins
Share to Down-Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to G1 Phase Cell Cycle Checkpoints

Share to Gene Knockdown Techniques

Share to Muscle Proteins

Share to Neoplasm Invasiveness

Share to RNA Interference

Source

Identifiers

PMID: 24833469
DOI: 10.1007/s11010-014-2086-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24833469-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Knockdown of response gene to complement 32 (RGC32) induces apoptosis and inhibits cell growth, migration, and invasion in human lung cancer cells.PMID 24833469Read ↗

RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC.Semantic proximity Read ↗

Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3.Semantic proximity Read ↗

Role of response gene to complement 32 in diseasesSemantic proximity Read ↗

Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancerSemantic proximity Read ↗

Role of C5b-9 and RGC-32 in CancerSemantic proximity Read ↗

Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects Against Pulmonary FibrosisSemantic proximity Read ↗

RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis.Semantic proximity Read ↗

Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivoSemantic proximity Read ↗

Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.Semantic proximity Read ↗

Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.Semantic proximity Read ↗

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.